Medical system and method for mouse myocardial infarction research
Through the medical system for mouse myocardial infarction research, including microsurgery, anesthesia, physiological monitoring and image collection, combined with linear regression model and drug tracking technology, the pressure and injury problems of surgery on mice were solved, and the experimental consistency was improved and repeatability reduces mice harm and effectively evaluates the therapeutic effect.
Patent Information
- Application Number
- CN202411372844.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-29
- Publication Date
- 2024-12-06
AI Technical Summary
In the study of myocardial infarction in mice, the surgical process caused physiological and psychological stress to the mice, resulting in stress responses, and there may be pain and physical damage after the operation. The existing technology is difficult to effectively solve these problems.
Provide medical systems for mouse myocardial infarction research, including microsurgery instruments, anesthesia instruments, physiological monitoring instruments, imaging acquisition instruments and postoperative drug transplantation tools, use linear regression models to predict the area of myocardial infarction and use fluorescent dyes or radiolabels. Track the distribution of therapeutic drugs and optimize the ligation location to reduce mice’s injury.
It improves the consistency and repeatability of the experiment, reduces the number of mice used and harm, accurately predicts the infarction area through mathematical modeling, and effectively evaluates the treatment effect.
Smart Images

Figure CN119074296A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of animal model analysis, and in particular to a medical system and method for studying myocardial infarction in mice. Background Art
[0002] The mouse myocardial infarction (MI) model is one of the commonly used experimental models in cardiovascular disease research. By establishing this model, researchers can better understand the pathophysiological process of myocardial infarction and test new treatments.
[0003] In the study of myocardial infarction (MI) in mice, specific strains of mice are usually selected as model animals, such as C57BL / 6J mice, because the cardiac anatomical structure and physiological function of these mice are closer to those of the human heart, making the research results more clinically transformative. The purpose of the study needs to be clarified during the experimental design phase, and the experimental and control groups need to be defined. Since the surgery itself will cause certain physiological and psychological pressure on mice and may lead to stress reactions, the research requires a large amount of experimental analysis. Despite analgesic measures, pain may still exist after surgery and mice may suffer certain damage to their bodies after MI.
[0004] Therefore, it is necessary to provide a new medical system and method for mouse myocardial infarction research to solve the above technical problems. Summary of the invention
[0005] In order to solve the above technical problems, the present invention provides a medical system and method for studying myocardial infarction in mice.
[0006] The medical system for myocardial infarction research in mice provided by the present invention comprises medical hardware and a medical data analysis module, wherein the medical hardware comprises a microsurgical instrument for locating and ligating the coronary artery of mice during surgery to establish a myocardial infarction model in mice;
[0007] Anesthesia equipment, used to anesthetize mice and ensure that the mice are in a proper anesthesia state during surgery;
[0008] Physiological monitoring equipment, used to monitor the physiological parameters of mice during surgery;
[0009] An image acquisition device used to collect cardiac imaging data during and after surgery on mice;
[0010] Postoperative drug transplantation tool, used to transplant therapeutic drugs to the corresponding target area of postoperative mice, and use fluorescent dyes or radioactive markers to label therapeutic drugs and track the distribution of therapeutic drugs in the body;
[0011] The medical data analysis module predicts the myocardial infarction area of the mouse according to the ligation position and ligation strength of the mouse myocardial infarction model using a linear regression model, so that the myocardial infarction area of the mouse reaches a balance point, and analyzes various indicator data obtained by physiological monitoring equipment and image acquisition equipment.
[0012] Furthermore, the postoperative drug transplantation tool includes a transplantation needle or catheter, which is selected to be directly injected into the myocardial infarction area or perfused through the coronary artery.
[0013] Furthermore, the physiological parameters include blood pressure and heart rate.
[0014] Furthermore, the microsurgical instruments include curved forceps, curved hemostatic forceps, and sutures.
[0015] Another aspect of the present invention provides an operating method for the above-mentioned medical system for myocardial infarction research in mice, the method comprising the following steps:
[0016] S1. Preoperative preparation: Select healthy mice, prepare microsurgical instruments, anesthetic drugs, physiological monitoring modules and image acquisition modules;
[0017] S2. Surgical operation: Use microsurgical instruments to locate and ligate the coronary arteries during surgery to establish a mouse myocardial infarction model;
[0018] S3. Postoperative treatment: Carefully suture the chest and skin incisions, remove the mice from the anesthesia box, and place them in a warm environment until they are fully awake. Use a transplant needle or catheter to directly inject the therapeutic drugs into the myocardial infarction area or perfuse them into the corresponding target area through the coronary artery. Use fluorescent dyes or radioactive markers to label the therapeutic drugs and track their distribution in the body.
[0019] S4. Postoperative evaluation and analysis: According to the ligation position and ligation strength of the mouse myocardial infarction model, a linear regression model is used to predict the myocardial infarction area of the mouse, so that the myocardial infarction area of the mouse reaches a balance point, and the various indicator data obtained by the physiological monitoring equipment and the image acquisition equipment are observed and analyzed.
[0020] Furthermore, the establishment of the mouse myocardial infarction model includes the following steps:
[0021] S1. Anesthesia: Mice were anesthetized using isoflurane inhalation.
[0022] S2, chest incision: make a 1cm-1.2cm long incision between the 3rd and 4th intercostal spaces on the left side, use curved forceps and curved hemostats to bluntly separate the pectoralis major muscle to expose the pectoralis minor muscle underneath the pectoralis major muscle;
[0023] S3. Expose the heart: Use blunt dissection to expose the heart;
[0024] S4, LAD ligation: Use suture to ligate the LAD artery near the apex;
[0025] S5. Confirm ischemia: Observe the color change of myocardium to confirm ischemia;
[0026] S6. Close the chest: Suture the chest and skin incisions;
[0027] S7. Recovery: Place the mouse on a heating pad until it is fully awake and monitor changes in its body temperature.
[0028] Furthermore, the method for predicting the myocardial infarction area in mice comprises the following steps:
[0029] S1. There is a functional relationship f(x) between the myocardial infarction area A and the ligation position x, and f(x) is in the form of a parabolic function:
[0030] f(x)=ax 2 +bx+c
[0031] Among them, a, b, c are unknown coefficients;
[0032] S2, parameter estimation: by collecting a set of ligation positions x i and the corresponding myocardial infarction area A i , construct a linear system of equations:
[0033]
[0034] Among them, ∈ i is the error term, representing the deviation between the model and the true data, and is calculated by minimizing the residual sum of squares The optimal estimated values of a, b, and c can be solved;
[0035] S3. After obtaining the optimal estimated values of a, b, and c, use f(x) to predict the myocardial infarction area at any ligation position x;
[0036] S4. Select a suitable x so that f(x) reaches a satisfactory equilibrium point.
[0037] Furthermore, the mice were anesthetized using isoflurane inhalation anesthesia with an initial concentration of 4-5% and a maintenance concentration of 2-3%.
[0038] Furthermore, during the process of monitoring the temperature changes of mice, a 60-watt lamp was used to maintain the body temperature of the mice.
[0039] Compared with the related art, the medical system and method for myocardial infarction research in mice provided by the present invention have the following beneficial effects:
[0040] 1. The present invention uses a linear regression model to predict the myocardial infarction area of mice according to the ligation position and ligation strength of the mouse myocardial infarction model, so that the myocardial infarction area of mice reaches a balance point. Through mathematical modeling, the infarction area under different ligation positions can be accurately predicted, and the consistency and repeatability of the experiment are improved. By optimizing the ligation position, consistent results can be obtained in fewer experiments, thereby reducing the number of mice used and the harm to mice.
[0041] 2. The present invention utilizes a postoperative drug transplantation tool to transplant therapeutic drugs of mice after surgery to the corresponding target area to repair damaged myocardial tissue, and utilizes fluorescent dyes or radioactive markers to label therapeutic drugs, track the distribution of therapeutic drugs in the body, and effectively evaluate the therapeutic effect. BRIEF DESCRIPTION OF THE DRAWINGS
[0042] Figure 1 This is a structural block diagram of the medical system for myocardial infarction research in mice provided by the present invention;
[0043] Figure 2 A flowchart of the operation method of the medical system for myocardial infarction research in mice provided by the present invention;
[0044] Figure 3 This is a flowchart of the establishment of the mouse myocardial infarction model provided by the present invention. DETAILED DESCRIPTION
[0045] The present invention will be further described below in conjunction with the accompanying drawings and implementation modes.
[0046] Please refer to Figure 1 , Figure 2 , Figure 3 ,in, Figure 1 This is a structural block diagram of the medical system for myocardial infarction research in mice provided by the present invention; Figure 2 A flowchart of the operation method of the medical system for myocardial infarction research in mice provided by the present invention; Figure 3 This is a flowchart of the establishment of the mouse myocardial infarction model provided by the present invention.
[0047] Embodiment 1
[0048] In the specific implementation process, Figure 1 As shown, the medical system for mouse myocardial infarction research includes microsurgical instruments: used for positioning and ligating the coronary arteries during mouse surgery to establish a mouse myocardial infarction model, and the microsurgical instruments include elbow forceps, elbow hemostatic forceps, and sutures;
[0049] Anesthesia equipment: used to anesthetize mice and ensure that they are in a proper anesthesia state during surgery;
[0050] Physiological monitoring equipment: used to monitor the physiological parameters of mice during surgery, including blood pressure and heart rate. Blood pressure measurement: monitor blood pressure changes through non-invasive or invasive methods. Heart rate measurement: record cardiac electrical activity and observe arrhythmias.
[0051] Image acquisition device: used to collect cardiac imaging data during and after mouse surgery;
[0052] Image acquisition equipment includes ultrasonic diagnostic instruments and electrocardiographs. Ultrasonic diagnostic instruments are used to evaluate cardiac function, such as measuring ejection fraction, cardiac systolic and diastolic function. Electrocardiographs are used to record cardiac electrical activity in mice, observe arrhythmias, and are used to evaluate the occurrence of myocardial infarction at an early stage.
[0053] Data analysis module: used to predict the myocardial infarction area of mice using a linear regression model based on the ligation position and ligation strength of the mouse myocardial infarction model, so that the myocardial infarction area of mice reaches a balance point, ensuring sufficient infarction area without causing excessive heart damage. By optimizing the ligation position, consistent results can be obtained in fewer experiments, thereby reducing the number of mice used and the harm to mice, and analyzing various indicator data obtained by physiological monitoring equipment and image acquisition equipment;
[0054] Postoperative drug transplantation tool: used to transplant therapeutic drugs to the corresponding target area of mice after surgery.
[0055] Postoperative drug transplantation tools include one or both of transplantation needles and catheters, which can be injected directly into the myocardial infarction area or infused through the coronary artery.
[0056] It should be noted that therapeutic drug transplantation repairs damaged myocardial tissue by transplanting specific types of cells. Appropriate cell types are selected, such as bone marrow mesenchymal stem cells (BMSCs) and myocardial progenitor cells, and cell culture is carried out under sterile conditions. Appropriate culture media and growth factors are used to promote cell proliferation. Impurities are removed by centrifugation, filtration and other means to ensure the purity of transplanted cells. Cells are labeled with fluorescent dyes or radioactive markers to track their distribution in the body and evaluate the therapeutic effect. Transplantation needles or catheter injections are used to ensure that cells can be accurately delivered to the target area.
[0057] In addition, appropriate drugs can be selected according to the research purpose, such as anticoagulants, analgesics, anti-inflammatory drugs, drugs that promote angiogenesis, or drugs that promote myocardial cell regeneration;
[0058] Dosage and frequency: Calculate the appropriate dose based on the drug properties and mouse weight to ensure that the drug can work without causing toxic side effects. Determine the dosing frequency based on the drug half-life and therapeutic goals, such as once a day or once every two days.
[0059] Embodiment 2
[0060] Another aspect of the present invention provides a method for operating a medical system for studying myocardial infarction in mice, referring to Figure 2 as well as Figure 3 As shown, the method comprises the following steps:
[0061] S1. Preoperative preparation: Select healthy mice, prepare microsurgical instruments, anesthetic drugs, physiological monitoring modules and image acquisition modules;
[0062] S2. Surgical operation: Use microsurgical instruments to locate and ligate the coronary arteries during surgery to establish a mouse myocardial infarction model;
[0063] S3. Postoperative treatment: Carefully suture the chest and skin incisions, remove the mice from the anesthesia box, and place them in a warm environment until they are fully awake. Use a transplant needle or catheter to directly inject the therapeutic drugs into the myocardial infarction area or perfuse them into the corresponding target area through the coronary artery, and use fluorescent dyes or radioactive markers to label the cells and track the distribution of cells in the body.
[0064] S4. Postoperative evaluation and analysis: According to the ligation position and ligation strength of the mouse myocardial infarction model, a linear regression model is used to predict the myocardial infarction area of the mouse, so that the myocardial infarction area of the mouse reaches a balance point, and the various indicator data obtained by the physiological monitoring equipment and the image acquisition equipment are observed and analyzed.
[0065] Furthermore, the establishment of the mouse myocardial infarction model includes the following steps:
[0066] S1. Anesthesia: Mice were anesthetized with isoflurane inhalation. The initial concentration of isoflurane inhalation was 4-5% and the maintenance concentration was 2-3%.
[0067] S2, chest incision: make a 1cm-1.2cm long incision between the 3rd and 4th intercostal spaces on the left side, use curved forceps and curved hemostats to bluntly separate the pectoralis major muscle to expose the pectoralis minor muscle underneath the pectoralis major muscle;
[0068] S3. Expose the heart: Use blunt dissection to expose the heart;
[0069] S4, LAD ligation: Use suture to ligate the LAD artery near the apex;
[0070] S5. Confirm ischemia: Observe the color change of myocardium to confirm ischemia;
[0071] S6. Close the chest: Suture the chest and skin incisions;
[0072] S7. Resuscitation: Place the mouse on a heating pad until it is fully awake, monitor the mouse's body temperature changes, and take measures such as irradiating it with a 60-watt lamp to maintain its body temperature (36°C to 37°C) to avoid dangerous hypothermia. This method can also be used if the mouse's body temperature drops during the operation. When irradiating to keep warm, the light bulb should be between 25 and 30 cm away from the mouse.
[0073] It should be noted that the prediction of myocardial infarction area in mice includes the following steps:
[0074] S1. There is a functional relationship f(x) between the myocardial infarction area A and the ligation position x, and f(x) is in the form of a parabolic function:
[0075] f(x)=ax 2 +bx+c
[0076] Among them, a, b, and c are unknown coefficients, which can be estimated by the least squares method based on experimental data;
[0077] S2, parameter estimation: by collecting a set of ligation positions x i and the corresponding myocardial infarction area A i , construct a linear system of equations:
[0078]
[0079] Among them, ∈ i is the error term, representing the deviation between the model and the true data, and is calculated by minimizing the residual sum of squares The optimal estimated values of a, b, and c can be solved;
[0080] S3. After obtaining the optimal estimated values of a, b, and c, use f(x) to predict the myocardial infarction area at any ligation position x;
[0081] S4. Select a suitable x so that f(x) reaches a satisfactory balance point, ensuring sufficient infarct area without causing excessive cardiac damage.
[0082] Through the description of the above implementation methods, those skilled in the art can clearly understand that each implementation method can be implemented by means of software plus a general hardware platform, and of course, by hardware. Based on this understanding, the above technical solution is essentially or the part that contributes to the relevant technology can be embodied in the form of a software product, and the computer software product can be stored in a computer-readable storage medium, such as ROM / RAM, a disk, an optical disk, etc., including a number of instructions for a computer device (which can be a personal computer, a server, or a network device, etc.) to execute the methods described in each embodiment or some parts of the embodiments.
[0083] The above shows and describes the basic principles and main features of the present invention and the advantages of the present invention. For those skilled in the art, it is obvious that the present invention is not limited to the details of the above exemplary embodiments, and the present invention can be implemented in other specific forms without departing from the spirit or basic features of the present invention. Therefore, no matter from which point of view, the embodiments should be regarded as exemplary and non-restrictive. The scope of the present invention is defined by the attached claims rather than the above description, and it is intended that all changes falling within the meaning and scope of the equivalent elements of the claims are included in the present invention, and any figure mark in the claims should not be regarded as limiting the claims involved.
[0084] In addition, it should be understood that although the present specification is described according to implementation modes, not every implementation mode contains only one independent technical solution. This description of the specification is only for the sake of clarity. Those skilled in the art should regard the specification as a whole. The technical solutions in each embodiment may also be appropriately combined to form other implementation modes that can be understood by those skilled in the art.
Claims
1. A medical system for myocardial infarction research in mice, comprising medical hardware and a medical data analysis module, characterized in that: The medical hardware includes microsurgical instruments for locating and ligating coronary arteries during surgery on mice to establish a mouse myocardial infarction model; Anesthesia equipment, used to anesthetize mice and ensure that the mice are in a proper anesthesia state during surgery; Physiological monitoring equipment, used to monitor the physiological parameters of mice during surgery; An image acquisition device used to collect cardiac imaging data during and after surgery on mice; Postoperative drug transplantation tool, used to transplant therapeutic drugs to the corresponding target area of postoperative mice, and use fluorescent dyes or radioactive markers to label therapeutic drugs and track the distribution of therapeutic drugs in the body; The medical data analysis module predicts the myocardial infarction area of the mouse according to the ligation position and ligation strength of the mouse myocardial infarction model using a linear regression model, so that the myocardial infarction area of the mouse reaches a balance point, and analyzes various indicator data obtained by physiological monitoring equipment and image acquisition equipment.
2. The medical system for myocardial infarction research in mice according to claim 1, characterized in that: The postoperative drug transplantation tool includes a transplantation needle or catheter, which is selected to be directly injected into the myocardial infarction area or perfused through the coronary artery.
3. The medical system for myocardial infarction research in mice according to claim 2, characterized in that: The physiological parameters include blood pressure and heart rate.
4. The medical system for myocardial infarction research in mice according to claim 3, characterized in that: The microsurgical instruments include elbow forceps, elbow hemostatic forceps, and sutures.
5. A method for operating the medical system for myocardial infarction research in mice according to any one of claims 1 to 4, characterized in that: The method comprises the following steps: S1. Preoperative preparation: Select healthy mice, prepare microsurgical instruments, anesthetic drugs, physiological monitoring modules and image acquisition modules; S2. Surgical operation: Use microsurgical instruments to locate and ligate the coronary arteries during surgery to establish a mouse myocardial infarction model; S3. Postoperative treatment: Carefully suture the chest and skin incisions, remove the mice from the anesthesia box, and place them in a warm environment until they are fully awake. Use a transplant needle or catheter to directly inject the therapeutic drugs into the myocardial infarction area or perfuse them into the corresponding target area through the coronary artery. Use fluorescent dyes or radioactive markers to label the therapeutic drugs and track their distribution in the body. S4. Postoperative evaluation and analysis: According to the ligation position and ligation strength of the mouse myocardial infarction model, a linear regression model is used to predict the myocardial infarction area of the mouse, so that the myocardial infarction area of the mouse reaches a balance point, and the various indicator data obtained by the physiological monitoring equipment and the image acquisition equipment are observed and analyzed.
6. The method for operating the medical system for myocardial infarction research in mice according to claim 5, characterized in that: The establishment of the mouse myocardial infarction model includes the following steps: S1. Anesthesia: Mice were anesthetized using isoflurane inhalation. S2, chest incision: make a 1cm-1.2cm long incision between the 3rd and 4th intercostal spaces on the left side, use curved forceps and curved hemostats to bluntly separate the pectoralis major muscle to expose the pectoralis minor muscle underneath the pectoralis major muscle; S3. Expose the heart: Use blunt dissection to expose the heart; S4, LAD ligation: Use suture to ligate the LAD artery near the apex; S5. Confirm ischemia: Observe the color change of myocardium to confirm ischemia; S6. Close the chest: Suture the chest and skin incisions; S7. Recovery: Place the mouse on a heating pad until it is fully awake and monitor changes in its body temperature.
7. The method for operating the medical system for myocardial infarction research in mice according to claim 6, characterized in that: The method for predicting the myocardial infarction area in mice comprises the following steps: S1. There is a functional relationship f(x) between the myocardial infarction area A and the ligation position x, and f(x) is in the form of a parabolic function: f(x)=ax 2 +bx+c Among them, a, b, c are unknown coefficients; S2, parameter estimation: by collecting a set of ligation positions x i and the corresponding myocardial infarction area A i , construct a linear system of equations: Among them, ∈ i is the error term, representing the deviation between the model and the true data, and is calculated by minimizing the residual sum of squares The optimal estimated values of a, b, and c can be solved; S3. After obtaining the optimal estimated values of a, b, and c, use f(x) to predict the myocardial infarction area at any ligation position x; S4. Select a suitable x so that f(x) reaches a satisfactory equilibrium point.
8. The method for operating the medical system for myocardial infarction research in mice according to claim 7, characterized in that: Mice were anesthetized using isoflurane inhalation anesthesia at an initial concentration of 4-5% and a maintenance concentration of 2-3%.
9. The method for operating the medical system for myocardial infarction research in mice according to claim 8, characterized in that: During the monitoring of the mouse body temperature changes, a 60-watt lamp was used to maintain the mouse body temperature.
